BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35093872)

  • 1. High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Model.
    Sugisawa N; Miyake K; Higuchi T; Oshiro H; Park JH; Kawaguchi K; Bouvet M; Unno M; Hoffman RM
    Anticancer Res; 2022 Feb; 42(2):739-743. PubMed ID: 35093872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively
    Park JH; Zhao M; Oshiro H; Miyake K; Higuchi T; Reynoso J; Razmjooei S; Bouvet M; Clary B; Zhang Z; Sugisawa N; Yamamoto J; Singh SR; Hoffman RM
    Anticancer Res; 2019 Jul; 39(7):3463-3467. PubMed ID: 31262870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug Screening.
    Kiyuna T; Murakami T; Tome Y; Igarashi K; Kawaguchi K; Russell T; Eckardt MA; Crompton J; Singh A; Bernthal N; Bukata S; Federman N; Kanaya F; Eilber FC; Hoffman RM
    J Cell Biochem; 2017 Feb; 118(2):361-365. PubMed ID: 27357060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Metastasis in a Patient-derived Orthotopic Xenograft (PDOX) Model of Undifferentiated Pleomorphic Sarcoma with Red Fluorescent Protein.
    Oshiro H; Kiyuna T; Tome Y; Miyake K; Kawaguchi K; Higuchi T; Miyake M; Zhang Z; Razmjooei S; Barangi M; Wangsiricharoen S; Nelson SD; Li Y; Bouvet M; Singh SR; Kanaya F; Hoffman RM
    Anticancer Res; 2019 Jan; 39(1):81-85. PubMed ID: 30591443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX).
    Hiroshima Y; Zhao M; Maawy A; Zhang Y; Katz MH; Fleming JB; Uehara F; Miwa S; Yano S; Momiyama M; Suetsugu A; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Cell Biochem; 2014 Jul; 115(7):1254-61. PubMed ID: 24435915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Stroma Labeling During Multiple Passage of a Sarcoma Imageable Patient-Derived Orthotopic Xenograft (iPDOX) in Red Fluorescent Protein Transgenic Nude Mice.
    Kiyuna T; Murakami T; Tome Y; Kawaguchi K; Igarashi K; Miyake K; Kanaya F; Singh A; Eilber FC; Hoffman RM
    J Cell Biochem; 2017 Oct; 118(10):3367-3371. PubMed ID: 28300287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-color palette of fluorescent proteins for imaging the tumor microenvironment of orthotopic tumorgraft mouse models of clinical pancreatic cancer specimens.
    Suetsugu A; Katz M; Fleming J; Truty M; Thomas R; Moriwaki H; Bouvet M; Saji S; Hoffman RM
    J Cell Biochem; 2012 Jul; 113(7):2290-5. PubMed ID: 22573550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive fluorescent-protein imaging of orthotopic pancreatic-cancer-patient tumorgraft progression in nude mice.
    Suetsugu A; Katz M; Fleming J; Truty M; Thomas R; Saji S; Moriwaki H; Bouvet M; Hoffman RM
    Anticancer Res; 2012 Aug; 32(8):3063-7. PubMed ID: 22843874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging the microenvironment of pancreatic cancer patient-derived orthotopic xenografts (PDOX) growing in transgenic nude mice expressing GFP, RFP, or CFP.
    Hoffman RM; Bouvet M
    Cancer Lett; 2016 Sep; 380(1):349-55. PubMed ID: 26742463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery.
    Yano S; Hiroshima Y; Maawy A; Kishimoto H; Suetsugu A; Miwa S; Toneri M; Yamamoto M; Katz MH; Fleming JB; Urata Y; Tazawa H; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Cancer Gene Ther; 2015 Jul; 22(7):344-50. PubMed ID: 26088297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of red fluorescent protein orthotopic transplantation nude mice metastasis model of pancreatic cancer and whole-body fluorescent imaging].
    Yu ZQ; Zhou JH; Tao KT; Hu L; Zheng J; Yang DT
    Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(14):1092-5. PubMed ID: 19781277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time whole-body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein.
    Yang M; Jiang P; Yamamoto N; Li L; Geller J; Moossa AR; Hoffman RM
    Prostate; 2005 Mar; 62(4):374-9. PubMed ID: 15389802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Color-Coded Imaging of Cancer and Stromal-Cell Interaction in the Pancreatic-Cancer Tumor Microenvironment (TME).
    Suetsugu A; Hoffman RM
    Methods Mol Biol; 2021; 2224():99-111. PubMed ID: 33606209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancer.
    Hiroshima Y; Maawy AA; Katz MH; Fleming JB; Bouvet M; Endo I; Hoffman RM
    J Surg Oncol; 2015 Mar; 111(3):311-5. PubMed ID: 25394368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models.
    Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Anticancer Res; 2016 Dec; 36(12):6273-6277. PubMed ID: 27919946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cyan fluorescent protein nude mouse as a host for multicolor-coded imaging models of primary and metastatic tumor microenvironments.
    Suetsugu A; Hassanein MK; Reynoso J; Osawa Y; Nagaki M; Moriwaki H; Saji S; Bouvet M; Hoffman RM
    Anticancer Res; 2012 Jan; 32(1):31-8. PubMed ID: 22213285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern.
    Hiroshima Y; Zhang Y; Zhang N; Maawy A; Mii S; Yamamoto M; Uehara F; Miwa S; Yano S; Murakami T; Momiyama M; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Murata T; Endo I; Hoffman RM
    PLoS One; 2015; 10(2):e0117417. PubMed ID: 25689852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) model.
    Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Nelson SD; Dry SM; Li Y; Russell TA; Singh AS; Chmielowski B; Unno M; Eilber FC; Hoffman RM
    Cell Cycle; 2017 Jun; 16(11):1063-1069. PubMed ID: 28426279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo imaging of pancreatic cancer with fluorescent proteins in mouse models.
    Bouvet M; Hoffman RM
    Methods Mol Biol; 2012; 872():51-67. PubMed ID: 22700403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice.
    Suemizu H; Monnai M; Ohnishi Y; Ito M; Tamaoki N; Nakamura M
    Int J Oncol; 2007 Oct; 31(4):741-51. PubMed ID: 17786304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.